EU Regulator Backs Novavax as Region’s Fifth COVID-19 Vaccine

The European Union’s drug regulator said on Monday it has approved the COVID-19 vaccine from U.S.-based Novavax for use in adults, paving the way for a fifth coronavirus shot in the EU as the Omicron coronavirus variant spreads. Read More